Yong Ik Jeong1, Charles Cantrell1, David Manglano1, Thomas Gallagher1, Jeffery Raizer1, Craig Horbinski1, and Timothy J Carroll1
Genetic profiling of cancers has the potential to identify epigenetic changes that predict response to treatments. In this study, we try to overcome the limitations posed by heterogeneity of tumor phenotypes by using normalized quantitative MRI to predict local gene expression. We report the findings of retrospectively comparing T1, T1 post Gd, T2 and ADC to Verhaak subtypes and pMGMT methylation status in histologically confirmed GBM patients.